Efficacy and safety of treatment with sofosbuvir/velpatasvir in patients aged 6–18 years with chronic hepatitis C—Results of the <scp>PANDAA‐PED</scp> study - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of treatment with sofosbuvir/velpatasvir in patients aged 6–18 years with chronic hepatitis C—Results of the <scp>PANDAA‐PED</scp> study

DOI Full Paper Access

15

Citations

14

References

2023

Year

Maria Pokorska‐Śpiewak, Ewa Talarek, Małgorzata Aniszewska, Magdalena Pluta, Anna Dobrzeniecka, Magdalena Marczyńska, Giuseppe Indolfi

Liver International

Abstract

Results of the PANDAA-PED study indicated a 100% effectiveness of a 12-week therapy with SOF/VEL in children aged 6-18 years with chronic HCV infection and its good safety profile, in particular in younger patients.

References

	Year	Citations

Page 1